Twenty years of selective hepatitis B vaccination: Is hepatitis B declining among injecting drug users in England and Wales?

Journal of Viral Hepatitis

Volumn 14, Issue 8, 2007, Pages 584-591

  Judd, A ^a   Hickman, M ^b,c   Hope, V D ^c,d   Sutton, A J ^d   Stimson, G V ^c,e   Ramsay, M E ^d   Gill, O N ^d   Parry, J V ^d  

^a MRC CLINICAL TRIALS UNIT   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d PUBLIC HEALTH ENGLAND   (United Kingdom)

^e HARM REDUCTION INTERNATIONAL   (United Kingdom)

Author keywords

Cross sectional study; England and Wales; Hepatitis B; Injecting drug use; London; Vaccination

Indexed keywords

HEPATITIS B CORE ANTIGEN; HEPATITIS B VACCINE;

ADULT; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOASSAY; INTRAVENOUS DRUG ABUSE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SALIVA ANALYSIS; UNITED KINGDOM; VIRUS IMMUNITY;

CROSS-SECTIONAL STUDIES; ENGLAND; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HUMANS; IMMUNIZATION; MALE; MODELS, IMMUNOLOGICAL; PREVALENCE; SUBSTANCE ABUSE, INTRAVENOUS; WALES;

EID: 34447554418     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2007.00844.x     Document Type: Article

References (30)

1. World Health Organization. Expanded programme on immunisation, global advisory group part 1. Wkly Epidemiol Rec 1992 3 : 11 16.
2. Heptonstall J. Strategies to ensure delivery of hepatitis B vaccine to injecting drug users. Commun Dis Public Health 1999 2 (3 154 156.
3. Lamagni TL, Davison KL, Hope VD et al. Poor hepatitis B vaccine coverage in injecting drug users: England, 1995 and 1996. Commun Dis Public Health 1999 2 (3 174 177.
4. Lamagni TL, Hope VD, Davison KL, Parry JV, Gill ON. Failure to vaccinate current injecting drug users against hepatitis B in England and Wales. Commun Dis Public Health 2001 4 (1 71 72.
5. Health Protection Agency. Acute Hepatitis B Infection Laboratory Reports: England and Wales, by Risk Group, 1990-2003. London : Health Protection Agency, 2004.
6. Hahne S, Ramsay M, Balogun K, Edmunds WJ, Mortimer P. Incidence and routes of transmission of hepatitis B virus in England and Wales, 1995-2000: implications for immunisation policy. J Clin Virol 2004 29 (4 211 220.
7. Simonsen L, Kane A, Lloyd J, Zaffran M, Kane M. Unsafe injections in the developing world and transmission of blood borne pathogens: a review. Bull World Health Organ 1999 77 (10 789 800.
8. Benenson AS. Control of Communicable Diseases Manual, 16th edn. Washington, DC : American Public Health Association, 1995.
9. Patel K, Muir AJ, McHutchison JG. Diagnosis and treatment of chronic hepatitis C infection. Br Med J 2006 332 (7548 1013 1017.
10. Vickerman P, Hickman M, Rhodes T, Watts C. Model projections on the required coverage of syringe distribution to prevent HIV epidemics among injecting drug users. J Acquir Immune Defic Syndr 2006 42 (3 355 361.
11. Rothman KJ, Greenland S. Modern epidemiology, 2nd edn. Philadelphia : Lippincott Williams & Wilkins, 1998.
12. Magder LS, Hughes JP. Logistic regression when the outcome is measured with uncertainty. Am J Epidemiol 1997 146 (2 195 203.
13. Unlinked Anonymous Surveys Steering Group. Prevalence of HIV and hepatitis infections in the United Kingdom 2001. London : Department of Health, 2002.
14. Hope VD, Ncube F, Hickman M, Judd A, Parry JV. Hepatitis B vaccine uptake among injecting drug users in England 1998 to 2004: is the prison vaccination programme driving recent improvements? J Viral Hepat., in press.
15. Stimson GV, Hunter GM, Donoghoe MC, Rhodes T, Parry JV, Chalmers CP. HIV-1 prevalence in community-wide samples of injecting drug users in London, 1990-1993. AIDS 1996 10 (6 657 666.
16. Judd A, Hunter GM, Maconochie N et al. HIV prevalence and risk behaviour among female injecting drug users in London, 1990 to 1996. AIDS 1999 13 (7 833 837.
17. Judd A, Stimson GV, Hickman M et al. Prevalence of HIV infection in a multi-site sample of injecting drug users not in contact with treatment services in England. AIDS 2000 14 (15 2413 2415.
18. Judd A, Hickman M, Jones S et al. Incidence of hepatitis C virus and HIV among new injecting drug users in London: prospective cohort study. Br Med J 2005 330 (7481 24 25.
19. Parry JV, Perry KR, Mortimer PP. Sensitive assays for viral antibodies in saliva: an alternative to tests on serum. Lancet 1987 2 (8550 72 75.
20. Evans AA, London WT. Epidemiology of hepatitis B. In : Zuckerman AJ, Thomas HC, eds. Viral Hepatitis. London : Churchill Livingstone, 1998 : 107 114.
21. Health Protection Agency, Health Protection Scotland, National Public Health Service for Wales, CDSC Northern Ireland, CRDHB, UASSG. Shooting Up: Infections among Injecting Drug Users in the United Kingdom 2004. London : Health Protection Agency, 2005.
22. Kirkwood BR, Sterne JA. Essential Medical Statistics, 2nd edn. Oxford : Blackwell Science Ltd, 2003.
23. Anderson RM, May RM. Infectious Diseases of Humans. Oxford : Oxford University Press, 1991.
24. Sutton AJ, Gay NJ, Edmunds WJ, Hope VD, Gill ON, Hickman M. Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales. BMC Infect Dis 2006 6 (1 93.
25. Hope VD, Judd A, Hickman M et al. HIV prevalence among injecting drug users in England and Wales 1990 to 2003: evidence for increased transmission in recent years. AIDS 2005 19 (11 1207 1214.
26. Vickerman P, Hickman M, Judd A. Modelling the impact on Hepatitis C transmission of reducing syringe sharing: London case study. Int J Epidemiol., in press.
27. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 2004 11 (2 97 107.
28. Levitt A, Vorsters A, Emiroglu N et al. Strengthening Immunisation Systems and Introduction of Hepatitis B Vaccine in Central and Eastern Europe and the Newly Independent States. Antwerp : Viral Hepatitis Prevention Board Secretariat, 2004.
29. Anonymous. Joint Committee on Vaccination and Immunisation hepatitis B sub-group: minutes of the meeting held on Monday 31 January 2005. http://www.advisorybodies.doh.gov.uk/jcvi/mins-hepb-310105.htm. Page viewed on 15 April 2006.
30. Perrett K, Granerod J, Crowcroft N, Carlisle R. Changing epidemiology of hepatitis A: should we be doing more to vaccinate injecting drug users? Commun Dis Public Health 2003 6 (2 97 100.